Medexus Pharmaceuticals Inc. (MEDXF)
OTCMKTS · Delayed Price · Currency is USD
2.080
+0.047 (2.29%)
Aug 22, 2025, 4:00 PM EDT
Medexus Pharmaceuticals Market Cap
Medexus Pharmaceuticals has a market cap or net worth of $66.17 million as of August 22, 2025. Its market cap has increased by 63.16% in one year.
Market Cap
66.17M
Enterprise Value
78.50M
Revenue
105.66M
Ranking
n/a
PE Ratio
82.09
Stock Price
$2.08
Market Cap Chart
Since December 27, 2013, Medexus Pharmaceuticals's market cap has increased from 30.10M to 66.17M, an increase of 119.80%. That is a compound annual growth rate of 6.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 21, 2025 | 66.17M | 11.39% |
Dec 31, 2024 | 59.40M | 29.86% |
Dec 29, 2023 | 45.74M | 48.80% |
Dec 30, 2022 | 30.74M | -23.08% |
Dec 31, 2021 | 39.97M | -48.56% |
Dec 31, 2020 | 77.70M | 82.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 972.93M |
Veradigm | 823.67M |
Glass House Brands | 632.06M |
Tian'an Technology Group | 628.15M |
Elite Pharmaceuticals | 587.83M |
American Oncology Network | 382.44M |
CytoDyn | 372.33M |
Northwest Biotherapeutics | 368.43M |